Trial Profile
A Study Evaluating Efficacy, Safety And Sustained Virologic Response Predicting Factors Of Sofosbuvir-Ledipasvir Treatment For Hepatitis C Virus (HCV)-Infected Patients In The Daily Practice Of A Tertiary Care Centre
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jan 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 04 Jan 2017 New trial record